​

Avita Medical (RCEL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RCEL Stock Forecast

Avita Medical (RCEL) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $11.00, with a high of $12.00 and a low of $10.00. This represents a 8.27% increase from the last price of $10.16.

$5 $8 $11 $14 $17 $20 High: $12 Avg: $11 Low: $10 Last Closed Price: $10.16

RCEL Stock Rating

Avita Medical stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 7 Strong Sell Sell Hold Buy Strong Buy

RCEL Price Target Upside V Benchmarks

TypeNameUpside
StockAvita Medical8.27%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks22.00%

Price Target Trends

1M3M12M
# Anlaysts237
Avg Price Target$11.50$10.00$7.64
Last Closing Price$10.16$10.16$10.16
Upside/Downside13.19%-1.57%-24.80%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26-3---3
Aug, 26-21--3
Jul, 26-21--3
Jun, 26-31--4
May, 26-31--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 28, 2026Lake Street$12.00$10.4814.50%18.11%
Aug 19, 2026Ryan ZimmermanBTIG$11.00$9.8511.68%8.27%
Aug 07, 2026Ryan ZimmermanBTIG$7.00$4.7547.37%-31.10%
May 15, 2026Lake Street$6.00$4.3637.61%-40.94%
Mar 26, 2026Northland Securities$10.00$3.86159.07%-1.57%
Jan 16, 2026Lake Street$3.50$3.60-2.78%-65.55%
Oct 17, 2025Frank TakkinenLake Street$4.00$5.38-25.65%-60.63%
Jan 08, 2025Brooks O'NeilLake Street$14.00$14.06-0.43%37.80%
May 14, 2024Matt O'BrienPiper Sandler$9.00$8.357.78%-11.42%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 28, 2026Lake StreetBuyBuyhold
Aug 19, 2026Cowen & Co.BuyBuyhold
Aug 19, 2026BTIGBuyBuyhold
Aug 07, 2026BTIGNeutralBuyupgrade
Jun 30, 2026Cowen & Co.BuyBuyhold
May 15, 2026Lake StreetHoldBuyupgrade
Jan 16, 2026Lake StreetHoldHoldhold
Nov 20, 2025BTIGSellNeutralupgrade
Oct 17, 2025Lake StreetBuyHolddowngrade
Aug 08, 2025BTIGBuySelldowngrade

Financial Forecast

EPS Forecast

$-5 $0 $5 $10 $15 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.03$-1.57$-1.40$-2.39$-1.74---
Avg Forecast$-2.77$-1.63$-2.48$-3.56$-1.12$1.43$9.11$16.90
High Forecast$-2.63$-1.57$-2.41$-3.20$-0.91$8.20$9.76$18.11
Low Forecast$-2.89$-1.80$-2.63$-3.77$-1.54$-0.97$8.72$16.17
Surprise %-62.82%-3.68%-43.55%-32.87%55.36%---

Revenue Forecast

$0 $140M $280M $420M $560M $700M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$33.02M$34.42M$50.14M$64.25M$71.61M---
Avg Forecast$25.34M$34.18M$50.14M$66.51M$103.68M$158.35M$368.30M$627.30M
High Forecast$26.15M$36.94M$52.89M$70.16M$109.36M$162.11M$388.50M$661.70M
Low Forecast$24.32M$33.08M$48.47M$64.30M$100.23M$154.59M$356.05M$606.43M
Surprise %30.33%0.69%--3.40%-30.93%---

Net Income Forecast

$-100M $20M $140M $260M $380M $500M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-25.14M$-26.66M$-35.38M$-61.84M$-48.59M---
Avg Forecast$-69.33M$-47.03M$-35.38M$-87.06M$-30.66M$28.81M$230.96M$422.60M
High Forecast$-65.72M$-37.62M$-28.30M$-79.99M$-22.81M$205.06M$244.01M$452.72M
Low Forecast$-72.20M$-56.44M$-42.46M$-94.13M$-38.52M$-24.24M$217.92M$404.32M
Surprise %-63.74%-43.30%--28.96%58.45%---

RCEL Forecast FAQ

Is Avita Medical stock a buy?

Avita Medical stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Avita Medical is a favorable investment for most analysts.

What is Avita Medical's price target?

Avita Medical's price target, set by 8 Wall Street analysts, averages $11 over the next 12 months. The price target range spans from $10 at the low end to $12 at the high end, suggesting a potential 8.27% change from the previous closing price of $10.16.

How does Avita Medical stock forecast compare to its benchmarks?

Avita Medical's stock forecast shows a 8.27% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (22.00%).

What is the breakdown of analyst ratings for Avita Medical over the past three months?

  • September 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Avita Medical’s EPS forecast?

Avita Medical's average annual EPS forecast for its fiscal year ending in December 2026 is $1.43, marking a -182.18% decrease from the reported $-1.74 in 2025. Estimates for the following years are $9.11 in 2027, and $16.9 in 2028.

What is Avita Medical’s revenue forecast?

Avita Medical's average annual revenue forecast for its fiscal year ending in December 2026 is $158.35M, reflecting a 121.13% increase from the reported $71.61M in 2025. The forecast for 2027 is $368.3M, and $627.3M for 2028.

What is Avita Medical’s net income forecast?

Avita Medical's net income forecast for the fiscal year ending in December 2026 stands at $28.81M, representing a -159.29% decrease from the reported $-48.587M in 2025. Projections indicate $230.96M in 2027, and $422.6M in 2028.